
    <!DOCTYPE html>
    <html>
    <head>
        <style>
            body { 
                font-family: 'Segoe UI', Roboto, -apple-system, sans-serif; 
                max-width: 1200px; 
                margin: 0 auto; 
                padding: 20px; 
                background-color: #f0f2f5;
                line-height: 1.6;
            }
            .container { 
                background-color: white; 
                padding: 40px; 
                border-radius: 16px; 
                box-shadow: 0 4px 12px rgba(0,0,0,0.1);
            }
            .agent-section { 
                margin-bottom: 35px; 
                padding: 25px; 
                border-radius: 12px; 
                transition: all 0.3s ease;
            }
            .agent-section:hover {
                transform: translateY(-2px);
                box-shadow: 0 4px 15px rgba(0,0,0,0.1);
            }
            .final-annotation { 
                background-color: #f0f7ff; 
                border-left: 5px solid #2196f3; 
            }
            .validator { 
                background-color: #f0fdf4; 
                border-left: 5px solid #22c55e; 
            }
            .formatting { 
                background: linear-gradient(145deg, #fff7ed, #ffe4c4);
                border-left: 5px solid #f97316; 
                box-shadow: 0 4px 15px rgba(249, 115, 22, 0.1);
            }
            h2 { 
                color: #1a2b3c; 
                margin-top: 0; 
                font-size: 1.5rem;
                font-weight: 600;
                display: flex;
                align-items: center;
                gap: 10px;
            }
            ul { 
                margin: 15px 0; 
                padding-left: 20px; 
            }
            pre { 
                background-color: #f8fafc; 
                padding: 20px; 
                border-radius: 8px; 
                overflow-x: auto;
                font-family: 'Consolas', 'Monaco', monospace;
                font-size: 0.9rem;
                line-height: 1.5;
            }
            .validation-result { 
                font-weight: 600; 
                color: #16a34a; 
                padding: 12px 20px;
                background-color: #dcfce7; 
                border-radius: 8px; 
                display: inline-block;
                margin: 10px 0;
            }
            br { 
                margin-bottom: 8px; 
            }
            p {
                margin: 12px 0;
                color: #374151;
            }
            .summary-content {
                display: flex;
                flex-direction: column;
                gap: 24px;
            }
            .summary-item {
                display: flex;
                flex-direction: column;
                gap: 8px;
                background: rgba(255, 255, 255, 0.7);
                padding: 16px;
                border-radius: 12px;
                backdrop-filter: blur(8px);
                box-shadow: 0 2px 8px rgba(0, 0, 0, 0.05);
            }
            .summary-label {
                font-weight: 600;
                color: #c2410c;
                font-size: 0.95rem;
                text-transform: uppercase;
                letter-spacing: 0.5px;
            }
            .summary-value {
                color: #1f2937;
                font-size: 1.1rem;
                padding: 8px 16px;
                background-color: rgba(255, 255, 255, 0.9);
                border-radius: 8px;
                display: inline-block;
                box-shadow: 0 1px 3px rgba(0, 0, 0, 0.1);
            }
            .summary-list {
                margin: 0;
                padding-left: 24px;
                list-style-type: none;
            }
            .summary-list li {
                color: #1f2937;
                padding: 8px 0;
                position: relative;
            }
            .summary-list li:before {
                content: "‚Ä¢";
                color: #f97316;
                font-weight: bold;
                position: absolute;
                left: -20px;
            }
            .report-header {
                text-align: center;
                margin-bottom: 40px;
                padding-bottom: 30px;
                border-bottom: 2px solid rgba(249, 115, 22, 0.2);
            }
            
            .report-title {
                font-size: 2.5rem;
                font-weight: 800;
                color: #1a2b3c;
                margin: 0;
                padding: 0;
                background: linear-gradient(135deg, #f97316, #c2410c);
                -webkit-background-clip: text;
                -webkit-text-fill-color: transparent;
                letter-spacing: -0.5px;
            }
            
            .report-subtitle {
                font-size: 1.1rem;
                color: #64748b;
                margin-top: 8px;
                font-weight: 500;
            }
            .scoring { 
                background: linear-gradient(145deg, #f0fdf4, #dcfce7);
                border-left: 5px solid #22c55e;
                box-shadow: 0 4px 15px rgba(34, 197, 94, 0.1);
            }
            .scoring-content {
                display: flex;
                flex-direction: column;
                gap: 16px;
                color: #1f2937;
                line-height: 1.8;
            }
            .scoring-content br + br {
                content: "";
                display: block;
                margin: 12px 0;
            }
            .empty-list {
                color: #6b7280;
                font-style: italic;
            }
            .error-message {
                color: #dc2626;
                padding: 12px;
                background-color: #fef2f2;
                border-radius: 6px;
                border-left: 4px solid #dc2626;
            }
            .score-badge {
                background: linear-gradient(135deg, #22c55e, #16a34a);
                color: white;
                padding: 8px 16px;
                border-radius: 12px;
                font-size: 1.5rem;
                font-weight: 700;
                display: inline-block;
                margin: 12px 0;
                box-shadow: 0 4px 12px rgba(34, 197, 94, 0.2);
                position: relative;
                top: -10px;
            }
            .score-badge::before {
                content: "Score:";
                font-size: 0.9rem;
                font-weight: 500;
                margin-right: 8px;
                opacity: 0.9;
            }
        </style>
    </head>
    <body>
        <div class="container">
            <div class="report-header">
                <h1 class="report-title">CASSIA Analysis Report</h1>
                <p class="report-subtitle">Comprehensive Cell Type Analysis and Annotation</p>
            </div>
            
                <div class="agent-section final-annotation">
                    <h2>üîç Final Annotation Analysis</h2>
                    To annotate the cell type from the provided ranked marker list, I will follow the outlined steps to ensure a comprehensive analysis.<br><br>### Step 1: List the Key Functional Markers<br>- **FASN (Fatty Acid Synthase):** Involved in lipogenesis, often upregulated in cancer cells for membrane synthesis.<br>- **SLC7A2 (Solute Carrier Family 7 Member 2):** Amino acid transporter, important for cellular metabolism.<br>- **MS4A7 (Membrane Spanning 4-Domains A7):** Associated with immune response.<br>- **MUC1 (Mucin 1):** A glycoprotein involved in forming protective mucous barriers and is often overexpressed in breast cancer.<br>- **PGR (Progesterone Receptor):** A nuclear receptor that mediates the effects of progesterone, often used as a marker in breast cancer.<br>- **CA12 (Carbonic Anhydrase 12):** Involved in pH regulation, often expressed in cancer cells.<br>- **MAPT (Microtubule Associated Protein Tau):** Stabilizes microtubules, associated with neuronal cells but also expressed in some cancers.<br>- **S100A14 (S100 Calcium Binding Protein A14):** Involved in cell cycle progression and differentiation.<br>- **IL6ST (Interleukin 6 Signal Transducer):** Part of the cytokine receptor complex, involved in immune signaling.<br><br>### Step 2: List the Key Cell Type Markers<br>- **MUC1:** Commonly used as a marker for epithelial cells, particularly in breast tissue.<br>- **PGR:** Indicates hormone receptor-positive breast cancer cells.<br>- **KRT19 (Keratin 19):** A marker for epithelial cells, often used in identifying breast cancer cells.<br>- **KRT7 (Keratin 7):** Another epithelial marker, often expressed in ductal cells of the breast.<br>- **PRLR (Prolactin Receptor):** Expressed in mammary gland cells, involved in lactation.<br>- **ANKRD30A (Ankyrin Repeat Domain 30A):** Known to be expressed in breast tissue.<br>- **ZG16B (Zymogen Granule Protein 16B):** Associated with secretory pathways in epithelial cells.<br><br>### Step 3: Cross-reference Known Databases<br>Using databases such as the Human Protein Atlas, CellMarker, and literature on breast cancer scRNA-seq, the markers MUC1, PGR, KRT19, and KRT7 are strongly associated with epithelial cells in breast tissue, particularly luminal epithelial cells. The presence of hormone receptors like PGR and PRLR further suggests a luminal subtype.<br><br>### Step 4: Determine the Most Probable General Cell Type<br>Based on the expression of epithelial markers (MUC1, KRT19, KRT7) and hormone receptors (PGR, PRLR), the most probable general cell type is **epithelial cells** from breast tissue.<br><br>### Step 5: Identify the Top 3 Most Probable Sub Cell Types<br>1. **Luminal Epithelial Cells:** High expression of MUC1, PGR, KRT19, and PRLR suggests luminal epithelial cells, which are common in breast tissue and often involved in breast cancer.<br>2. **Luminal Progenitor Cells:** These cells express similar markers but may have a slightly different profile, including markers like ANKRD30A.<br>3. **Basal Epithelial Cells:** Although less likely due to the lack of specific basal markers, they can sometimes express KRT19 and KRT7.<br><br>The most likely subtype based on the markers is **Luminal Epithelial Cells**.<br><br>### Step 6: Provide a Concise Summary of Your Analysis<br>The analysis of the ranked marker list from the breast cancer tissue dataset suggests that the cell cluster is most likely composed of epithelial cells, specifically luminal epithelial cells. This conclusion is supported by the high expression of epithelial markers (MUC1, KRT19, KRT7) and hormone receptors (PGR, PRLR), which are characteristic of luminal epithelial cells in breast tissue.<br><br>FINAL ANNOTATION COMPLETED
                </div>
            
                <div class="agent-section validator">
                    <h2>‚úì Validation Check</h2>
                    <div class="validation-result">‚úÖ VALIDATION PASSED</div>
                    Validation result: VALIDATION PASSED<br><br>The proposed annotation result is consistent with the provided marker list and the identified cell type. Here's the breakdown:<br><br>1. **Marker Consistency:**<br>   - The key functional markers and cell type markers mentioned in the annotation (e.g., MUC1, PGR, KRT19, KRT7, PRLR, ANKRD30A, ZG16B) are present in the provided marker list.<br>   - The markers used to identify the cell type as epithelial cells, specifically luminal epithelial cells, are consistent with known markers for these cell types.<br><br>2. **Mixed Cell Type Consideration:**<br>   - The annotation does not strongly suggest the presence of multiple distinct cell types. The markers predominantly support the identification of luminal epithelial cells, with no strong evidence for a mixed population based on the high-ranking markers provided.<br><br>The annotation process followed a logical and thorough approach, cross-referencing known databases and literature, and the conclusion aligns well with the marker data provided.
                </div>
            
                        <div class="agent-section formatting">
                            <h2>üìã Summary</h2>
                            
                        <div class="summary-content">
                            <div class="summary-item">
                                <span class="summary-label">Main Cell Type:</span>
                                <span class="summary-value">Epithelial Cells</span>
                            </div>
                            
                            <div class="summary-item">
                                <span class="summary-label">Sub Cell Types:</span>
                                <ul class="summary-list">
                                    <li>Luminal Epithelial Cells</li><li>Luminal Progenitor Cells</li><li>Basal Epithelial Cells</li>
                                </ul>
                            </div>
                            
                            <div class="summary-item">
                                <span class="summary-label">Possible Mixed Cell Types:</span>
                                <ul class="summary-list">
                                    <li class="empty-list">No mixed cell types identified</li>
                                </ul>
                            </div>
                            
                            <div class="summary-item">
                                <span class="summary-label">Number of Markers:</span>
                                <span class="summary-value">50</span>
                            </div>
                        </div>
                    
                        </div>
                    
                    <div class="agent-section scoring">
                        <h2>üéØ Quality Assessment</h2>
                        <div class="score-badge">90</div>
                        <div class="scoring-content">
                            The annotation results provided demonstrate a well-structured and logical approach to identifying the cell types present in the single-cell dataset derived from human breast cancer tissue. The analysis effectively utilizes a combination of functional and cell type-specific markers to arrive at a conclusion, which is a strength of this annotation.<br><br>1. **Correctness of the Annotations:**<br>   - The identification of epithelial cells, specifically luminal epithelial cells, is scientifically accurate given the presence of key markers such as MUC1, PGR, KRT19, and KRT7. These markers are well-documented in the literature as being associated with luminal epithelial cells in breast tissue.<br>   - The annotation also considers hormone receptors like PGR and PRLR, which are relevant in the context of breast cancer, further supporting the conclusion.<br><br>2. **Balanced Consideration of Multiple Markers:**<br>   - The annotation process does a commendable job of balancing the use of different markers. It does not overly focus on a single marker but rather integrates information from multiple markers to support the identification of the cell type.<br>   - The analysis includes both functional markers (e.g., FASN, SLC7A2) and cell type markers (e.g., MUC1, KRT19), providing a comprehensive view of the cell population.<br><br>3. **Ability to Capture the General Picture:**<br>   - The annotation captures the general picture of the cell population by identifying the most probable cell type and subtypes. The identification of luminal epithelial cells as the primary cell type is consistent with the marker data and the known biology of breast cancer.<br>   - The consideration of potential subtypes, such as luminal progenitor cells and basal epithelial cells, adds depth to the analysis, although the evidence for these subtypes is less strong.<br><br>4. **Consideration of Marker Rank:**<br>   - The analysis does not explicitly discuss the rank of the markers, which could be a minor oversight. However, the markers used are indeed high-ranking and relevant, which mitigates this issue to some extent.<br><br>Overall, the annotation is thorough and well-reasoned, with no obvious misclassifications or oversights. The use of databases and literature to cross-reference the markers adds credibility to the conclusions drawn.<br>
                        </div>
                    </div>
                
        </div>
    </body>
    </html>
    